111 Capital Buys New Stake in Plexus Corp. $PLXS

Key Points

• 111 Capital purchased a new stake in Plexus Corp. during the second quarter, acquiring 2,510 shares valued at approximately $340,000.
• Plexus Corp.'s latest quarterly earnings surpassed analysts' expectations, reporting an EPS of $1.90 and revenue of $1.02 billion, with a year-over-year revenue increase of 6.0%.
• Several institutional investors significantly increased their holdings in Plexus, resulting in institutional ownership now at 94.45% of the company’s stock.

111 Capital bought a new stake in Plexus Corp. (NASDAQ:PLXS - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 2,510 shares of the technology company's stock, valued at approximately $340,000.

Several other institutional investors have also recently added to or reduced their stakes in PLXS. Fuller & Thaler Asset Management Inc. increased its holdings in Plexus by 120.4% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company's stock valued at $44,655,000 after purchasing an additional 190,360 shares during the last quarter. Nuveen LLC acquired a new position in shares of Plexus in the first quarter worth $22,975,000. American Century Companies Inc. grew its stake in shares of Plexus by 24.7% in the first quarter. American Century Companies Inc. now owns 678,222 shares of the technology company's stock worth $86,901,000 after acquiring an additional 134,205 shares in the last quarter. Millennium Management LLC grew its stake in shares of Plexus by 85.1% in the first quarter. Millennium Management LLC now owns 228,116 shares of the technology company's stock worth $29,229,000 after acquiring an additional 104,904 shares in the last quarter. Finally, Invesco Ltd. grew its stake in shares of Plexus by 66.1% in the first quarter. Invesco Ltd. now owns 211,741 shares of the technology company's stock worth $27,130,000 after acquiring an additional 84,249 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company's stock.

Plexus Stock Performance

Shares of PLXS opened at $148.85 on Tuesday. The stock has a 50 day moving average price of $136.53 and a 200 day moving average price of $131.87. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $4.02 billion, a price-to-earnings ratio of 25.36 and a beta of 0.80. Plexus Corp. has a 52-week low of $103.43 and a 52-week high of $172.89.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.19. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The firm's quarterly revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.45 earnings per share. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Research analysts predict that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Patrick John Jermain sold 2,500 shares of Plexus stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $137.71, for a total transaction of $344,275.00. Following the sale, the chief financial officer owned 20,959 shares in the company, valued at approximately $2,886,263.89. The trade was a 10.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $143.70, for a total value of $215,550.00. Following the sale, the chief executive officer owned 69,214 shares in the company, valued at $9,946,051.80. This trade represents a 2.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,856 shares of company stock valued at $2,142,440 over the last ninety days. Company insiders own 1.76% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Sidoti upgraded shares of Plexus from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $135.00 to $150.00 in a research note on Friday, July 25th. Stifel Nicolaus set a $140.00 price target on shares of Plexus in a research note on Thursday, July 24th. Benchmark boosted their price target on shares of Plexus from $160.00 to $165.00 and gave the stock a "buy" rating in a research note on Monday, September 22nd. Williams Trading set a $165.00 price target on shares of Plexus in a research note on Monday, September 22nd. Finally, Needham & Company LLC decreased their price objective on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $155.60.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.